Clinical validation of qPCR Target Selector™ assays using highly specific switch-blockers for rare mutation detection | Journal of Clinical Pathology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via ACP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Original research

Clinical validation of qPCR Target Selector™ assays using highly specific switch-blockers for rare mutation detection

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Arnold L, Alexiadis V, watanaskul T, et al

Clinical validation of qPCR Target Selector™ assays using highly specific switch-blockers for rare mutation detection

Journal of Clinical Pathology 2020;73:648-655.